AT

Akebia Therapeutics

AKBA
NASDAQHealth Care

Income Statement

Total Revenue$160.18M
Gross Profit$97M
Operating Income$-47.25M
EBITDA$-51.23M
EBIT$-51.23M
Pre-tax Income$-18.76M
Net Income$-69.41M

Balance Sheet

Cash Equivalent$41.84M
Total Debt$55.29M
Book Value$-40.15M
Book Value Per Share-0.19

Key Ratios

Return on Equity (ROE)-1811.54%
Return on Assets (ROA)-31.45%
Return on Invested Capital (ROI)-132.12%
Net Profit Margin-43.33%
Current Ratio1.41
Quick Ratio1.07
Long-Term Debt / Equity6.56